Publications by authors named "Scott Keating"

Claim this Profile
S
Seismic constraints on glacier density.
Ariane Lanteri, Scott Keating, Lars Gebraad, Sara Klaasen, Marta Pienkowska-Côte

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia.
Andrew J Klink, Scott J Keating, John Brokars, Bruce Feinberg, Elias Jabbour

Clin Lymphoma Myeloma Leuk· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and costs among US patients with diffuse large B-cell lymphoma not treated with 2L stem cell transplantation.
Teofilia Acheampong, Tao Gu, Trong Kim Le, Scott J Keating

Future Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Cost per Clinical Outcome of Second-Line Liso-Cel Versus Autologous Stem Cell Transplantation in Patients with Transplantation-Intended Relapsed/Refractory Large B Cell Lymphoma.
Matia Saeedian, Jack Badaracco, Afraim Botros, Matthew Gitlin, Scott J Keating

Transplant Cell Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States.
Christopher Parker, Fei Fei Liu, Kristen A Deger, Conrado Franco-Villalobos, Irina Proskorovsky, Scott J Keating

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model to Estimate Cytokine Release Syndrome and Neurological Event Management Costs Associated With CAR T-Cell Therapy.
Jack Badaracco, Matthew Gitlin, Scott J Keating

Transplant Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United States.
Scott J Keating, Tao Gu, Monika P Jun, Ali McBride

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials.
M Lia Palomba, Monika Parisi Jun, James Lymp, Andy Nguyen, November McGarvey, Scott J Keating

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to the use of metformin: patient and provider perspectives.
James H Flory, Scott Keating, Dominique Guelce, Alvin I Mushlin

Patient Prefer Adherence· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record.
James H Flory, Scott Justin Keating, David Siscovick, Alvin I Mushlin

BMJ Open· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
James Flory, Tobias Gerhard, Nikita Stempniewicz, Scott Keating, Christopher G Rowan

Diabetes Obes Metab· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis